TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

JANUS HENDERSON GROUP PLC's Holding History (CIK: 0001274173)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 6,356,000 Value ($000) $7,183 Avg Close Range
Q2 2025
Shares 11,391,000 Value ($000) $10,848 Avg Close Range
Q1 2025
Shares 10,394,000 Value ($000) $10,735 Avg Close Range
Q4 2024
Shares 4,771,000 Value ($000) $4,554 Avg Close Range